{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T14:49:07Z","timestamp":1777819747017,"version":"3.51.4"},"reference-count":85,"publisher":"International Society of Endovascular Specialists","issue":"SupplementI","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Endovascular Therapy"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1583\/08-2564.1","type":"journal-article","created":{"date-parts":[[2009,6,1]],"date-time":"2009-06-01T12:45:29Z","timestamp":1243860329000},"page":"I-170-I-182","source":"Crossref","is-referenced-by-count":9,"title":["Restenosis After Lower Extremity Interventions:\n                    <b>Current Status and Future Directions<\/b>"],"prefix":"10.1583","volume":"16","author":[{"given":"Nicolas W.","family":"Shammas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"527","reference":[{"key":"i1545-1550-16-SupplementI-170-b1","doi-asserted-by":"crossref","unstructured":"K. Kandarpa, G. J. Becker, and M. G. Hunink .et al.Transcatheter interventions for the treatment of peripheral atherosclerotic lesions: part I., J Vasc Interv Radiol, 2001 .12 :683 \u2013695 .","DOI":"10.1016\/S1051-0443(07)61438-9"},{"key":"i1545-1550-16-SupplementI-170-b2","doi-asserted-by":"crossref","unstructured":"J. R. Laird, Limitations of percutaneous transluminal angioplasty and stenting for the treatment of disease of the superficial femoral and popliteal arteries., J Endovasc Ther, 2006 .13 Suppl 2 :II30 \u201340 .","DOI":"10.1177\/15266028060130S207"},{"key":"i1545-1550-16-SupplementI-170-b3","unstructured":"N. W. Shammas, M. J. Kapalis, and E. J. Dippel .et al.Clinical and angiographic predictors of restenosis following renal artery stenting., J Invasive Cardiol, 2004 .16 :10 \u201313 ."},{"key":"i1545-1550-16-SupplementI-170-b4","doi-asserted-by":"crossref","unstructured":"H. Dub\u00e9, A. G. Clifford, and C. M. Barry .et al.Comparison of the vascular responses to balloon-expandable stenting in the coronary and peripheral circulations: long-term results in an animal model using the TriMaxx stent., J Vasc Surg, 2007 .45 :821 \u2013827 .","DOI":"10.1016\/j.jvs.2006.12.012"},{"key":"i1545-1550-16-SupplementI-170-b5","doi-asserted-by":"crossref","unstructured":"M. Schillinger, and E. Minar .Restenosis after percutaneous angioplasty: the role of vascular inflammation., Vasc Health Risk Manag, 2005 .1 :73 \u201378 .","DOI":"10.2147\/vhrm.1.1.73.58932"},{"key":"i1545-1550-16-SupplementI-170-b6","doi-asserted-by":"crossref","unstructured":"M. Schillinger, M. Exner, and W. Mlekusch .et al.Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis., Radiology, 2002 .225 :21 \u201326 .","DOI":"10.1148\/radiol.2251011809"},{"key":"i1545-1550-16-SupplementI-170-b7","doi-asserted-by":"crossref","unstructured":"M. Schillinger, M. Exner, and W. Mlekusch .et al.Inflammatory response to stent implantation: differences in femoropopliteal, iliac, and carotid arteries., Radiology, 2002 .224 :529 \u2013535 .","DOI":"10.1148\/radiol.2241011253"},{"key":"i1545-1550-16-SupplementI-170-b8","doi-asserted-by":"crossref","unstructured":"M. Schillinger, M. Exner, and W. Mlekusch .et al.Endovascular revascularization below the knee: 6-month results and predictive value of C-reactive protein level., Radiology, 2003 .227 :419 \u2013425 .","DOI":"10.1148\/radiol.2272020137"},{"key":"i1545-1550-16-SupplementI-170-b9","doi-asserted-by":"crossref","unstructured":"M. Schillinger, M. Exner, and W. Mlekusch .et al.Fibrinogen predicts restenosis after endovascular treatment of the iliac arteries., Thromb Haemost, 2002 .87 :959 \u2013965 .","DOI":"10.1055\/s-0037-1613118"},{"key":"i1545-1550-16-SupplementI-170-b10","doi-asserted-by":"crossref","unstructured":"W. S. Speidl, M. Exner, and J. Amighi .et al.Complement component C5a predicts restenosis after superficial femoral artery balloon angioplasty., J Endovasc Ther, 2007 .14 :62 \u201369 .","DOI":"10.1583\/06-1946.1"},{"key":"i1545-1550-16-SupplementI-170-b11","doi-asserted-by":"crossref","unstructured":"E. Laxdal, G. E. Eide, and J. Wirsching .et al.Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the above-knee femoropopliteal artery., Eur J Vasc Endovasc Surg, 2004 .28 :410 \u2013417 .","DOI":"10.1016\/j.ejvs.2004.06.010"},{"key":"i1545-1550-16-SupplementI-170-b12","doi-asserted-by":"crossref","unstructured":"M. Schillinger, M. Exner, and W. Mlekusch .et al.Restenosis after femoropopliteal PTA and elective stent implantation: predictive value of monocyte counts., J Endovasc Ther, 2003 .10 :557 \u2013565 .","DOI":"10.1177\/152660280301000322"},{"key":"i1545-1550-16-SupplementI-170-b13","doi-asserted-by":"crossref","unstructured":"B. Ray, I. C. Chetter, and H. L. Lee .et al.Plasma tissue factor is a predictor for restenosis after femoropopliteal angioplasty., Br J Surg, 2007 .94 :1092 \u20131095 .","DOI":"10.1002\/bjs.5759"},{"key":"i1545-1550-16-SupplementI-170-b14","doi-asserted-by":"crossref","unstructured":"M. Schillinger, M. Haumer, and G. Schlerka .et al.Restenosis after percutaneous transluminal angioplasty in the femoropopliteal segment: the role of inflammation., J Endovasc Ther, 2001 .8 :477 \u2013483 .","DOI":"10.1177\/152660280100800509"},{"key":"i1545-1550-16-SupplementI-170-b15","doi-asserted-by":"crossref","unstructured":"M. G. Hunink, M. C. Donaldson, and M. F. Meyerovitz .et al.Risks and benefits of femoropopliteal percutaneous balloon angioplasty., J Vasc Surg, 1993 .17 :183 \u2013192 .","DOI":"10.1016\/0741-5214(93)90022-E"},{"key":"i1545-1550-16-SupplementI-170-b16","doi-asserted-by":"crossref","unstructured":"M. G. Davies, W. E. Saad, and E. K. Peden .et al.Percutaneous superficial femoral artery interventions for claudication: does runoff matter? Ann Vasc Surg, 2008 Jul 18. [Epub ahead of print] .","DOI":"10.1016\/j.avsg.2008.04.007"},{"key":"i1545-1550-16-SupplementI-170-b17","doi-asserted-by":"crossref","unstructured":"A. Abando, G. Akopian, and S. G. Katz .Patient sex and success of peripheral percutaneous transluminal arterial angioplasty., Arch Surg, 2005 .140 :757 \u2013761 .","DOI":"10.1001\/archsurg.140.8.757"},{"key":"i1545-1550-16-SupplementI-170-b18","unstructured":"B. van der Loo, T. Kovacevic, and E. Krieger .et al.Blood fluidity and outcome after femoropopliteal percutaneous transluminal angioplasty (PTA): role of plasma viscosity and low platelet count in predicting restenosis., Clin Hemorheol Microcirc, 2005 .32 :159 \u2013168 ."},{"key":"i1545-1550-16-SupplementI-170-b20","doi-asserted-by":"crossref","unstructured":"A. Gallino, F. Mahler, and P. Probst .et al.Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up., Circulation, 1984 .70 :619 \u2013623 .","DOI":"10.1161\/01.CIR.70.4.619"},{"key":"i1545-1550-16-SupplementI-170-b21","unstructured":"P. Capek, G. K. McLean, and H. D. Berkowitz .Femoropopliteal angioplasty. Factors influencing long-term success., Circulation, 1991 .83 :(2 Suppl).I70 \u201380 ."},{"key":"i1545-1550-16-SupplementI-170-b22","doi-asserted-by":"crossref","unstructured":"K. A. Giles, F. B. Pomposelli, and A. D. Hamdan .et al.Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs., J Vasc Surg, 2008 .48 :128 \u2013136 .","DOI":"10.1016\/j.jvs.2008.02.027"},{"key":"i1545-1550-16-SupplementI-170-b23","doi-asserted-by":"crossref","unstructured":"T. P. Sarac, O. Altinel, and M. Bannazadeh .et al.Midterm outcome predictors for lower extremity atherectomy procedures., J Vasc Surg, 2008 Aug 8. [Epub ahead of print] .","DOI":"10.1016\/j.jvs.2008.05.072"},{"key":"i1545-1550-16-SupplementI-170-b24","doi-asserted-by":"crossref","unstructured":"E. Tetteroo, Y. van der Graaf, and J. L. Bosch .et al.Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group., Lancet, 1998 .351 :1153 \u20131159 .","DOI":"10.1016\/S0140-6736(97)09508-1"},{"key":"i1545-1550-16-SupplementI-170-b25","doi-asserted-by":"crossref","unstructured":"J. L. Bosch, and M. G. Hunink .Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease., Radiology, 1997 .204 :87 \u201396 .","DOI":"10.1148\/radiology.204.1.9205227"},{"key":"i1545-1550-16-SupplementI-170-b26","doi-asserted-by":"crossref","unstructured":"A. F. AbuRahma, J. D. Hayes, and S. K. Flaherty .et al.Primary iliac stenting versus transluminal angioplasty with selective stenting., J Vasc Surg, 2007 .46 :965 \u2013970 .","DOI":"10.1016\/j.jvs.2007.07.027"},{"key":"i1545-1550-16-SupplementI-170-b27","doi-asserted-by":"crossref","unstructured":"D. Ponec, M. R. Jaff, and J. Swischuk .et al.The Nitinol SMART stent vs Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results., J Vasc Interv Radiol, 2004 .15 :911 \u2013918 .","DOI":"10.1097\/01.RVI.0000140935.45313.35"},{"key":"i1545-1550-16-SupplementI-170-b28","doi-asserted-by":"crossref","unstructured":"M. Schillinger, S. Sabeti, and C. Loewe .et al.Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery., N Engl J Med, 2006 .354 :1879 \u20131888 .","DOI":"10.1056\/NEJMoa051303"},{"key":"i1545-1550-16-SupplementI-170-b29","doi-asserted-by":"crossref","unstructured":"M. Schillinger, S. Sabeti, and P. Dick .et al.Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting., Circulation, 2007 .115 :2745 \u20132749 .","DOI":"10.1161\/CIRCULATIONAHA.107.688341"},{"key":"i1545-1550-16-SupplementI-170-b30","doi-asserted-by":"crossref","unstructured":"H. Krankenberg, M. Schl\u00fcter, and H. J. Steinkamp .et al.Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST)., Circulation, 2007 .116 :285 \u2013292 .","DOI":"10.1161\/CIRCULATIONAHA.107.689141"},{"key":"i1545-1550-16-SupplementI-170-b31","doi-asserted-by":"crossref","unstructured":"A. J. Taylor, P. D. Gorman, and B. Kenwood .et al.A comparison of four stent designs on arterial injury, cellular proliferation, neointima formation, and arterial dimensions in an experimental porcine model., Catheter Cardiovasc Interv, 2001 .53 :420 \u2013425 .","DOI":"10.1002\/ccd.1194"},{"key":"i1545-1550-16-SupplementI-170-b32","doi-asserted-by":"publisher","DOI":"10.1583\/05-1672.1"},{"key":"i1545-1550-16-SupplementI-170-b33","doi-asserted-by":"crossref","unstructured":"S. Sabeti, M. Schillinger, and J. Amighi .et al.Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis., Radiology, 2004 .232 :516 \u2013521 .","DOI":"10.1148\/radiol.2322031345"},{"key":"i1545-1550-16-SupplementI-170-b34","doi-asserted-by":"crossref","unstructured":"A. Mongiardo, A. Curcio, and C. Spaccarotella .et al.Molecular mechanisms of restenosis after percutaneous peripheral angioplasty and approach to endovascular therapy., Curr Drug Targets Cardiovasc Haematol Disord, 2004 .4 :275 \u2013287 .","DOI":"10.2174\/1568006043336258"},{"key":"i1545-1550-16-SupplementI-170-b35","doi-asserted-by":"crossref","unstructured":"D. Scheinert, S. Scheinert, and J. Sax .et al.Prevalence and clinical impact of stent fractures after femoropopliteal stenting., J Am Coll Cardiol, 2005 .45 :312 \u2013315 .","DOI":"10.1016\/j.jacc.2004.11.026"},{"key":"i1545-1550-16-SupplementI-170-b36","doi-asserted-by":"crossref","unstructured":"R. Kickuth, H. H. Keo, and J. Triller .et al.Initial clinical experience with the 4-F self-expanding XPERT stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia., J Vasc Interv Radiol, 2007 .18 :703 \u2013708 .","DOI":"10.1016\/j.jvir.2007.03.012"},{"key":"i1545-1550-16-SupplementI-170-b37","doi-asserted-by":"crossref","unstructured":"G. Tepe, T. Zeller, and S. Heller .et al.Self-expanding nitinol stents for treatment of infragenicular arteries following unsuccessful balloon angioplasty., Eur Radiol, 2007 .17 :2088 \u20132095 .","DOI":"10.1007\/s00330-006-0526-5"},{"key":"i1545-1550-16-SupplementI-170-b38","doi-asserted-by":"crossref","unstructured":"N. W. Shammas, E. J. Dippel, and G. Shammas .et al.Dethrombosis of the lower extremity arteries using the power-pulse spray technique in patients with recent onset thrombotic occlusions: results of the DETHROMBOSIS Registry., J Endovasc Ther, 2008 .15 :570 \u2013579 .","DOI":"10.1583\/08-2453.1"},{"key":"i1545-1550-16-SupplementI-170-b39","doi-asserted-by":"crossref","unstructured":"R. H. Samson, D. P. Showalter, and M. R. Lepore .et al.Cryoplasty therapy of the superficial femoral and popliteal arteries: a single center experience., Vasc Endovascular Surg, 2006 .40 :446 \u2013450 .","DOI":"10.1177\/1538574406290048"},{"key":"i1545-1550-16-SupplementI-170-b40","doi-asserted-by":"crossref","unstructured":"M. Fava, S. Loyola, and A. Polydorou .et al.Cryoplasty for femoropopliteal arterial disease: late angiographic results of initial human experience., J Vasc Interv Radiol, 2004 .15 :1239 \u20131243 .","DOI":"10.1097\/01.RVI.0000136291.07304.EA"},{"key":"i1545-1550-16-SupplementI-170-b41","doi-asserted-by":"crossref","unstructured":"J. Laird, M. R. Jaff, and G. Biamino .et al.Cryoplasty for the treatment of femoropopliteal arterial disease: results of a prospective, multicenter registry., J Vasc Interv Radiol, 2005 .16 :1067 \u20131073 .","DOI":"10.1097\/01.RVI.0000167866.86201.4E"},{"key":"i1545-1550-16-SupplementI-170-b42","doi-asserted-by":"crossref","unstructured":"J. R. Laird, G. Biamino, and T. McNamara .et al.Cryoplasty for the treatment of femoropopliteal arterial disease: extended follow-up results., J Endovasc Ther, 2006 .13 :(Suppl 2).II52 \u201359 .","DOI":"10.1177\/15266028060130S209"},{"key":"i1545-1550-16-SupplementI-170-b43","doi-asserted-by":"crossref","unstructured":"M. Wildgruber, W. Weiss, and H. Berger .et al.Early endothelial and haematological response to cryoplasty compared with balloon angioplasty of the superficial femoral artery\u2013a pilot study., Br J Radiol, 2007 .80 :430 \u2013436 .","DOI":"10.1259\/bjr\/12495386"},{"key":"i1545-1550-16-SupplementI-170-b44","doi-asserted-by":"crossref","unstructured":"S. Karthik, D. J. Tuite, and A. A. Nicholson .et al.Cryoplasty for arterial restenosis., Eur J Vasc Endovasc Surg, 2007 .33 :40 \u201343 .","DOI":"10.1016\/j.ejvs.2006.07.010"},{"key":"i1545-1550-16-SupplementI-170-b45","unstructured":"D. O. Kessel, and R. H. Samson .What is the evidence for the efficacy of cryoplasty? J Cardiovasc Surg (Torino), 2008 .49 :179 \u2013185 ."},{"key":"i1545-1550-16-SupplementI-170-b46","doi-asserted-by":"crossref","unstructured":"J. Amighi, M. Schillinger, and P. Dick .et al.De novo superficial femoropopliteal artery lesions: peripheral cutting balloon angioplasty and restenosis rates\u2013randomized controlled trial., Radiology, 2008 .248 :297 \u2013302 .","DOI":"10.1148\/radiol.2481071159"},{"key":"i1545-1550-16-SupplementI-170-b47","doi-asserted-by":"crossref","unstructured":"R. Albiero, S. Silber, and C. Di Mario .et al.Cutting balloon versus conventional balloon angioplasty for the treatment of in-stent restenosis: results of the restenosis cutting balloon evaluation trial (RESCUT)., J Am Coll Cardiol, 2004 .43 :943 \u2013949 .","DOI":"10.1016\/j.jacc.2003.09.054"},{"key":"i1545-1550-16-SupplementI-170-b48","doi-asserted-by":"crossref","unstructured":"R. Vikram, R. A. Ross, and R. Bhat .et al.Cutting balloon angioplasty versus standard balloon angioplasty for failing infrainguinal vein grafts: comparative study of short- and mid-term primary patency rates., Cardiovasc Intervent Radiol, 2007 .30 :607 \u2013610 .","DOI":"10.1007\/s00270-007-9005-x"},{"key":"i1545-1550-16-SupplementI-170-b49","doi-asserted-by":"crossref","unstructured":"L. Mauri, R. Bonan, and B. H. Weiner .et al.Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized Trial., Am J Cardiol, 2002 .90 :1079 \u20131083 .","DOI":"10.1016\/S0002-9149(02)02773-X"},{"key":"i1545-1550-16-SupplementI-170-b50","doi-asserted-by":"crossref","unstructured":"V. Ramaiah, R. Gammon, and S. Kiesz .et al.Midterm outcomes from the TALON Registry: treating peripherals with SilverHawk: outcomes collection., J Endovasc Ther, 2006 .13 :592 \u2013602 .","DOI":"10.1583\/05-1780MR.1"},{"key":"i1545-1550-16-SupplementI-170-b51","doi-asserted-by":"crossref","unstructured":"D. Vroegindeweij, A. V. Tielbeek, and J. Buth .et al.Directional atherectomy versus balloon angioplasty in segmental femoropopliteal artery disease: two-year follow-up with color-flow duplex scanning., J Vasc Surg, 1995 .21 :255 \u2013268 .","DOI":"10.1016\/S0741-5214(95)70267-9"},{"key":"i1545-1550-16-SupplementI-170-b52","doi-asserted-by":"crossref","unstructured":"S. W. Chung, M. J. Sharafuddin, and R. Chigurupati .et al.Midterm patency following atherectomy for infrainguinal occlusive disease: a word of caution., Ann Vasc Surg, 2008 .22 :358 \u2013365 .","DOI":"10.1016\/j.avsg.2007.12.014"},{"key":"i1545-1550-16-SupplementI-170-b54","doi-asserted-by":"crossref","unstructured":"D. Scheinert, J. R. Laird, and M. Schr\u00f6der .et al.Excimer laser-assisted recanalization of long, chronic superficial femoral artery occlusions., J Endovasc Ther, 2001 .8 :156 \u2013166 .","DOI":"10.1177\/152660280100800210"},{"key":"i1545-1550-16-SupplementI-170-b55","doi-asserted-by":"crossref","unstructured":"H. J. Steinkamp, C. Wissgott, and J. Rademaker .et al.Short (1\u201310 cm) superficial femoral artery occlusions: results of treatment with excimer laser angioplasty., Cardiovasc Intervent Radiol, 2002 .25 :388 \u2013396 .","DOI":"10.1007\/s00270-002-1864-6"},{"key":"i1545-1550-16-SupplementI-170-b56","doi-asserted-by":"crossref","unstructured":"M. C. Stoner, D. J. deFreitas, and S. V. Phade .et al.Mid-term results with laser atherectomy in the treatment of infrainguinal occlusive disease., J Vasc Surg, 2007 .46 :289 \u2013295 .","DOI":"10.1016\/j.jvs.2007.04.019"},{"key":"i1545-1550-16-SupplementI-170-b57","doi-asserted-by":"publisher","DOI":"10.1583\/1074-6218(1995)002<0067:IAUTAR>2.0.CO;2"},{"key":"i1545-1550-16-SupplementI-170-b58","doi-asserted-by":"crossref","unstructured":"R. M. Wolfram, A. C. Budinsky, and B. Pokrajac .et al.Endovascular brachytherapy: restenosis in de novo versus recurrent lesions of femoropopliteal artery\u2013the Vienna experience., Radiology, 2005 .236 :338 \u2013342 .","DOI":"10.1148\/radiol.2361040084"},{"key":"i1545-1550-16-SupplementI-170-b59","doi-asserted-by":"crossref","unstructured":"T. Zehnder, C. von Briel, and I. Baumgartner .et al.Endovascular brachytherapy after percutaneous transluminal angioplasty of recurrent femoropopliteal obstructions., J Endovasc Ther, 2003 .10 :304 \u2013311 .","DOI":"10.1177\/152660280301000221"},{"key":"i1545-1550-16-SupplementI-170-b60","doi-asserted-by":"crossref","unstructured":"N. Diehm, A. Silvestro, and D. D. Do .et al.Endovascular brachytherapy after femoropopliteal balloon angioplasty fails to show robust clinical benefit over time., J Endovasc Ther, 2005 .12 :723 \u2013730 .","DOI":"10.1583\/05-1583MR.1"},{"key":"i1545-1550-16-SupplementI-170-b61","doi-asserted-by":"crossref","unstructured":"R. M. Wolfram, A. C. Budinsky, and B. Pokrajac .et al.Vascular brachytherapy with 192Ir after femoropopliteal stent implantation in high-risk patients: twelve-month follow-up results from the Vienna-5 trial., Radiology, 2005 .236 :343 \u2013351 .","DOI":"10.1148\/radiol.2361040696"},{"key":"i1545-1550-16-SupplementI-170-b62","doi-asserted-by":"crossref","unstructured":"K. Narayan, M. Denton, and R. Das .et al.A Phase II study of external-beam radiotherapy and endovascular brachytherapy with PTA and stenting for femoropopliteal artery restenosis., Int J Radiat Oncol Biol Phys, 2006 .66 :238 \u2013243 .","DOI":"10.1016\/j.ijrobp.2006.04.024"},{"key":"i1545-1550-16-SupplementI-170-b63","doi-asserted-by":"crossref","unstructured":"P. Fritz, U. Stein, and C. Hasslacher .et al.External beam radiotherapy fails to prevent restenosis after iliac or femoropopliteal percutaneous transluminal angioplasty: results of a prospective randomized double-blind study., Int J Radiat Oncol Biol Phys, 2004 .59 :815 \u2013821 .","DOI":"10.1016\/j.ijrobp.2003.11.036"},{"key":"i1545-1550-16-SupplementI-170-b64","doi-asserted-by":"crossref","unstructured":"M. Pai, W. Jamal, and A. Mosse .et al.Inhibition of in-stent restenosis in rabbit iliac arteries with photodynamic therapy., Eur J Vasc Endovasc Surg, 2005 .30 :573 \u2013581 .","DOI":"10.1016\/j.ejvs.2005.07.003"},{"key":"i1545-1550-16-SupplementI-170-b65","doi-asserted-by":"crossref","unstructured":"M. P. Jenkins, G. A. Buonaccorsi, and R. Mansfield .et al.Reduction in the response to coronary and iliac artery injury with photodynamic therapy using 5-aminolevulinic acid., Cardiovasc Res, 2000 .45 :478 \u2013485 .","DOI":"10.1016\/S0008-6363(99)00352-1"},{"key":"i1545-1550-16-SupplementI-170-b66","doi-asserted-by":"crossref","unstructured":"E. E. Gabeler, R. van Hillegersberg, and R. G. Statius van Eps .et al.Endovascular photodynamic therapy with aminolevulinic acid prevents balloon induced intimal hyperplasia and constrictive remodelling., Eur J Vasc Endovasc Surg, 2002 .24 :322 \u2013331 .","DOI":"10.1053\/ejvs.2002.1723"},{"key":"i1545-1550-16-SupplementI-170-b67","doi-asserted-by":"crossref","unstructured":"M. P. Jenkins, G. A. Buonaccorsi, and M. Raphael .et al.Clinical study of adjuvant photodynamic therapy to reduce restenosis following femoral angioplasty., Br J Surg, 1999 .86 :1258 \u20131263 .","DOI":"10.1046\/j.1365-2168.1999.01247.x"},{"key":"i1545-1550-16-SupplementI-170-b68","doi-asserted-by":"crossref","unstructured":"O. Iida, S. Nanto, and M. Uematsu .et al.Cilostazol reduces target lesion revascularization after percutaneous transluminal angioplasty in the femoropopliteal artery., Circ J, 2005 .69 :1256 \u20131259 .","DOI":"10.1253\/circj.69.1256"},{"key":"i1545-1550-16-SupplementI-170-b69","doi-asserted-by":"crossref","unstructured":"O. Iida, S. Nanto, and M. Uematsu .et al.Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions., J Vasc Surg, 2008 .48 :144 \u2013149 .","DOI":"10.1016\/j.jvs.2008.02.062"},{"key":"i1545-1550-16-SupplementI-170-b70","doi-asserted-by":"crossref","unstructured":"H. Ishii, Y. Kumada, and T. Toriyama .et al.Cilostazol improves long-term patency after percutaneous transluminal angioplasty in hemodialysis patients with peripheral artery disease., Clin J Am Soc Nephrol, 2008 .3 :1034 \u20131040 .","DOI":"10.2215\/CJN.05761207"},{"key":"i1545-1550-16-SupplementI-170-b71","doi-asserted-by":"crossref","unstructured":"A. Gallino, D. D. Do, and M. Alerci .et al.Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial., J Endovasc Ther, 2004 .11 :595 \u2013604 .","DOI":"10.1583\/04-1269MR.1"},{"key":"i1545-1550-16-SupplementI-170-b72","doi-asserted-by":"crossref","unstructured":"R. Waksman, R. Pakala, and R. Baffour .et al.Optimal dosing and duration of oral everolimus to inhibit in-stent neointimal growth in rabbit iliac arteries., Cardiovasc Revasc Med, 2006 .7 :179 \u2013184 .","DOI":"10.1016\/j.carrev.2006.05.001"},{"key":"i1545-1550-16-SupplementI-170-b73","doi-asserted-by":"crossref","unstructured":"H. Keo, D. D. Do, and M. Husmann .et al.Oral sirolimus for prevention of recurrent infrainguinal arterial obstructions after surgical and endovascular revascularizations., Vasa, 2008 .37 :285 \u2013288 .","DOI":"10.1024\/0301-1526.37.3.285"},{"key":"i1545-1550-16-SupplementI-170-b74","doi-asserted-by":"crossref","unstructured":"J. Hausleiter, A. Kastrati, and J. Mehilli .et al.Randomized, double-blind, placebo-controlled trial of oral sirolimus for restenosis prevention in patients with in-stent restenosis: the Oral Sirolimus to Inhibit Recurrent In-stent Stenosis (OSIRIS) trial., Circulation, 2004 .110 :790 \u2013795 .","DOI":"10.1161\/01.CIR.0000138935.17503.35"},{"key":"i1545-1550-16-SupplementI-170-b75","doi-asserted-by":"crossref","unstructured":"A. E. Rodriguez, J. F. Granada, and M. Rodriguez-Alemparte .et al.Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study., J Am Coll Cardiol, 2006 .47 :1522 \u20131529 .","DOI":"10.1016\/j.jacc.2005.12.052"},{"key":"i1545-1550-16-SupplementI-170-b76","doi-asserted-by":"crossref","unstructured":"A. J. Chaves, A. G. Sousa, and L. A. Mattos .et al.Pilot study with an intensified oral sirolimus regimen for the prevention of in-stent restenosis in de novo lesions: a serial intravascular ultrasound study., Catheter Cardiovasc Interv, 2005 .66 :535 \u2013540 .","DOI":"10.1002\/ccd.20538"},{"key":"i1545-1550-16-SupplementI-170-b77","doi-asserted-by":"crossref","unstructured":"G. Tepe, T. Zeller, and T. Albrecht .et al.Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg., N Engl J Med, 2008 .358 :689 \u2013699 .","DOI":"10.1056\/NEJMoa0706356"},{"key":"i1545-1550-16-SupplementI-170-b78","doi-asserted-by":"crossref","unstructured":"S. H. Duda, M. Bosiers, and J. Lammer .et al.Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial., J Endovasc Ther, 2006 .13 :701 \u2013710 .","DOI":"10.1583\/05-1704.1"},{"key":"i1545-1550-16-SupplementI-170-b79","doi-asserted-by":"crossref","unstructured":"S. H. Duda, M. Bosiers, and J. Lammer .et al.Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial., J Vasc Interv Radiol, 2005 .16 :331 \u2013338 .","DOI":"10.1097\/01.RVI.0000151260.74519.CA"},{"key":"i1545-1550-16-SupplementI-170-b80","unstructured":"M. Bosiers, K. Deloose, and J. Verbist .et al.Percutaneous transluminal angioplasty for treatment of \u201cbelow-the-knee\u201d critical limb ischemia: early outcomes following the use of sirolimus-eluting stents., J Cardiovasc Surg (Torino), 2006 .47 :171 \u2013176 ."},{"key":"i1545-1550-16-SupplementI-170-b81","doi-asserted-by":"publisher","DOI":"10.1583\/05-1620MR.1"},{"key":"i1545-1550-16-SupplementI-170-b82","doi-asserted-by":"publisher","DOI":"10.1583\/1545-1550(2007)14[241:SVBSAS]2.0.CO;2"},{"key":"i1545-1550-16-SupplementI-170-b83","doi-asserted-by":"crossref","unstructured":"P. Commeau, P. Barragan, and P. O. Roquebert .Sirolimus for below the knee lesions: mid-term results of SiroBTK study., Catheter Cardiovasc Interv, 2006 .68 :793 \u2013798 .","DOI":"10.1002\/ccd.20893"},{"key":"i1545-1550-16-SupplementI-170-b84","doi-asserted-by":"crossref","unstructured":"D. Siablis, D. Karnabatidis, and K. Katsanos .et al.Infrapopliteal application of paclitaxel-eluting stents for critical limb ischemia: midterm angiographic and clinical results., J Vasc Interv Radiol, 2007 .18 :1351 \u20131361 .","DOI":"10.1016\/j.jvir.2007.07.018"},{"key":"i1545-1550-16-SupplementI-170-b85","doi-asserted-by":"crossref","unstructured":"E. P. Strecker, A. Gabelmann, and I. Boos .et al.Effect on intimal hyperplasia of dexamethasone released from coated metal stents compared with non-coated stents in canine femoral arteries., Cardiovasc Intervent Radiol, 1998 .21 :487 \u2013496 .","DOI":"10.1007\/s002709900309"},{"key":"i1545-1550-16-SupplementI-170-b86","doi-asserted-by":"crossref","unstructured":"P. H. Lin, N. A. Chronos, and M. M. Marijianowski .et al.Heparin-coated balloon-expandable stent reduces intimal hyperplasia in the iliac artery in baboons., J Vasc Interv Radiol, 2003 .14 :603 \u2013611 .","DOI":"10.1097\/01.RVI.0000071088.76348.23"},{"key":"i1545-1550-16-SupplementI-170-b87","doi-asserted-by":"publisher","DOI":"10.1583\/08-2397.1"}],"container-title":["Journal of Endovascular Therapy"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:29:00Z","timestamp":1777498140000},"score":1,"resource":{"primary":{"URL":"http:\/\/jet.sagepub.com\/lookup\/doi\/10.1583\/08-2564.1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":85,"journal-issue":{"issue":"SupplementI","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1583\/08-2564.1"],"URL":"https:\/\/doi.org\/10.1583\/08-2564.1","relation":{},"ISSN":["1526-6028","1545-1550"],"issn-type":[{"value":"1526-6028","type":"print"},{"value":"1545-1550","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}